WHO Treatment Guidelines for Drug-Resistant Tuberculosis
The WHO treatment guidelines for drug-resistant TB contains policy recommendations on priority areas in the treatment of drug-resistant TB.
The WHO treatment guidelines for drug-resistant TB contains policy recommendations on priority areas in the treatment of drug-resistant TB.
This resource provides access to a variety of tools that enable health professionals to quickly and easily find information about TB in an emergency department setting.
WHO has published a global TB report every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease at global, regional and country levels. This report is updated annually.
This brochure describes Mycobacterium bovis (bovine tuberculosis) in humans and in cattle.
This document describes the steps necessary to implement the shorter regimen and the new drugs for drug-resistant TB treatment, including diagnosis and bacterial confirmation of drug resistance, treatment regimen design, monitoring of treatment efficacy and safety, and programmatic evaluation.
This fact sheet provides an overview of treating TB disease in persons infected with HIV/AIDS.
This report presents summary data for U.S. TB cases reported to the Division of TB Elimination, CDC, during 2015.
This activity book is designed to educate children regarding basic TB concepts. Activities include a crossword puzzle, a word search, and a matching game.
This infographic provides an overview of the global TB epidemic.
The 2016 ATS/CDC/IDSA Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis webinar provides an overview of the guidelines development process, key changes in recommendations, and the evidence supporting the changes.